Q1 2025 Brightspring Health Services Inc Earnings Call Transcript
Key Points
- BrightSpring Health Services Inc (BTSG) reported a strong start to 2025 with first-quarter results exceeding expectations.
- Total company revenue grew by 26% year-over-year, reaching $2.9 billion.
- Pharmacy solutions revenue increased by 28% year-over-year, driven by strong performance in Onco360 and CareMed specialty pharmacy businesses.
- Adjusted EBITDA for the company grew by 28% compared to the same period last year, indicating improved operational efficiency.
- The company increased its total revenue and adjusted EBITDA guidance for 2025, reflecting confidence in continued growth.
- The company is facing regulatory scrutiny with a second request for review from the SEC regarding the planned divestiture of the community living business.
- There are uncertainties related to potential future pharma tariffs, which could impact the company's operations.
- The leap year in 2024 resulted in fewer days in Q1 2025, negatively impacting EBITDA by $3.7 million.
- Gross margin was impacted by a mix of revenue, with larger growth in the specialty pharmacy business, which carries lower than corporate average gross margins.
- The company is subject to potential impacts from the Inflation Reduction Act (IRA) and Medicaid discussions, although it currently does not foresee significant changes.
Thank you for standing by. Welcome to the BrightSpring Health Services, first quarter 2025 earnings conference call. (Operator Instructions) As a reminder, today's program is being recorded, and now I'd like to introduce your host for today's program, David Deuchler, Investor Relations. Please go ahead.
Good morning. Thank you for participating in today's conference call. My name is David Deuchler with Investor Relations for BrightSpring. I'm joined on today's call by Jon Rousseau, Chief Executive Officer; and Jen Phipps, Chief Financial Officer. Earlier today, BrightSpring released financial results for the quarter end of March 31, 2025. A copy of the press release and presentation is available on the company's Investor Relations website.
Please note that today's discussion will include certain forward-looking statements that reflect our current assumptions and expectations, including those related to our future financial performance in industry and market conditions. Such forward
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
